{
  "normal": {
    "name": "Normal physiology",
    "short": "Normal physiology",
    "stage": "Stage 1 · Physiology",
    "sig": "The reference rectangle",
    "desc": "A textbook resting loop: EF ~55%, SV ~80 mL, 120/80 mmHg. Ventriculo-arterial coupling (Ea/Ees) sits near 0.7, so the heart delivers stroke work at close to maximum efficiency.",
    "chips": [
      "EF ~55%",
      "SV ~80 mL",
      "Ea/Ees ~0.7"
    ],
    "evidence": "Physiologic reference: Sagawa 1988; Suga 1979 elastance framework.",
    "teach": "<p>The loop runs <strong>counter-clockwise</strong> through four phases. The width is <strong>stroke volume</strong>; the enclosed area is <strong>stroke work</strong>.</p><p>Three boundary lines define the space. <em>ESPVR</em> (top-left) is set by contractility. <em>EDPVR</em> (bottom) is set by passive stiffness. <em>Ea</em> (the diagonal) is the arterial load the ventricle ejects against.</p><div class=\"pearl\"><b>Anchor point:</b> peak LV pressure ≈ aortic systolic pressure here. The ventricle and the aorta communicate through a wide-open valve. Keep that in mind; in aortic stenosis they diverge.</div>"
  },
  "exercise": {
    "name": "Exercise",
    "short": "Exercise / catecholamines",
    "stage": "Stage 1 · Physiology",
    "sig": "Bigger and taller",
    "desc": "Sympathetic drive raises contractility (steeper ESPVR) while venous return raises preload. The loop grows in every direction: more SV, higher pressure, higher output.",
    "chips": [
      "↑Ees",
      "↑preload",
      "↑CO"
    ],
    "evidence": "Contractile & Frank–Starling reserve; Sunagawa coupling reserve.",
    "teach": "<p>Exercise recruits <strong>both</strong> preload (venous return) and contractility (β-adrenergic ESPVR steepening). Stroke volume and output climb together.</p><p>Note that <strong>Ea/Ees falls</strong>. Contractility rises faster than load, so coupling shifts toward the efficient end. This is <em>contractile reserve</em>.</p><div class=\"pearl\"><b>Real hearts also raise heart rate;</b> this fixed-rate model shows only the per-beat mechanics, so output here is conservative.</div>"
  },
  "hypovol": {
    "name": "Hypovolaemia",
    "short": "Hypovolaemia / haemorrhage",
    "stage": "Stage 1 · Physiology",
    "sig": "Small loop, shifted left",
    "desc": "Loss of circulating volume drops preload. The loop slides down the EDPVR and shrinks, with a lower SV and a lower pressure, while EF is preserved because contractility is untouched.",
    "chips": [
      "↓EDV",
      "↓SV",
      "EF preserved"
    ],
    "evidence": "Frank–Starling descent; classic haemorrhage physiology.",
    "teach": "<p>Everything hinges on <strong>preload</strong>. Less filling → the loop starts further left on the EDPVR → smaller stroke volume by the Frank–Starling mechanism.</p><p>Because ESPVR (contractility) is <strong>unchanged</strong>, ejection fraction stays normal even as output falls. EF is a poor marker of volume status.</p><div class=\"pearl\"><b>Bedside link:</b> this is the loop of a fluid-responsive patient. Give volume and the loop climbs back up the Starling curve.</div>"
  },
  "dobut": {
    "name": "Dobutamine / inotrope",
    "short": "Inotrope (dobutamine)",
    "stage": "Stage 1 · Physiology",
    "sig": "Steeper ESPVR, smaller ESV",
    "desc": "An inotrope steepens the ESPVR: the ventricle empties to a smaller end-systolic volume at the same afterload, so SV and EF rise. Mild vasodilation lowers afterload too.",
    "chips": [
      "↑↑Ees",
      "↓ESV",
      "↑EF"
    ],
    "evidence": "β1-agonism; ESPVR slope as load-independent inotropy (Suga–Sagawa).",
    "teach": "<p>Inotropes act on the <strong>ESPVR slope</strong>. A steeper line means the same end-systolic pressure is reached at a much smaller volume. The ventricle empties more completely.</p><p>The result is a taller, wider loop with a low ESV. Efficiency improves, but at a real cost the loop does not show: <strong>myocardial oxygen demand rises</strong>.</p><div class=\"pearl\"><b>Contrast with preload:</b> a fluid bolus moves you along a fixed ESPVR; an inotrope tilts the ESPVR itself.</div>"
  },
  "vasocon": {
    "name": "Pure afterload increase",
    "short": "Vasoconstriction (↑afterload)",
    "stage": "Stage 1 · Physiology",
    "sig": "Tall and narrow",
    "desc": "Raising afterload alone (vasopressor, hypertension) tilts Ea steeper. The aortic valve opens later and closes sooner, so ESV climbs and SV falls. The loop grows taller but narrows.",
    "chips": [
      "↑Ea",
      "↑ESV",
      "↓SV"
    ],
    "evidence": "Afterload sensitivity; steeper Ea reduces SV at fixed Ees.",
    "teach": "<p>Afterload is the diagonal <em>Ea</em> line. Steepen it and the loop must reach a higher pressure to eject. The aortic valve opens later, and the loop closes at a <strong>higher end-systolic volume</strong>.</p><p>Net effect: taller, narrower loop, lower stroke volume. The failing ventricle is far more afterload-sensitive than the normal one.</p><div class=\"pearl\"><b>Coupling shifts up:</b> Ea/Ees rises. Push it far enough and the heart uncouples from its load.</div>"
  },
  "vasodil": {
    "name": "Vasodilation / afterload reduction",
    "short": "Vasodilator (↓afterload)",
    "stage": "Stage 1 · Physiology",
    "sig": "Wider, lower loop",
    "desc": "Lowering afterload flattens Ea. The valve opens earlier, ESV falls, and SV rises. This is the mechanism behind afterload reduction in heart failure.",
    "chips": [
      "↓Ea",
      "↓ESV",
      "↑SV"
    ],
    "evidence": "Vasodilator therapy in HFrEF; afterload-reduction physiology.",
    "teach": "<p>Drop the afterload and the ventricle empties more completely: <strong>lower ESV, larger SV</strong>. The loop widens and drops.</p><p>This is why afterload reduction helps the failing heart so much more than the normal one. A flat, weak ESPVR is very sensitive to afterload.</p><div class=\"pearl\"><b>Load a failing preset, then reduce MAP:</b> watch SV jump. Now do the same on the normal heart. It barely moves.</div>"
  },
  "hf": {
    "name": "Systolic HF (HFrEF)",
    "short": "Systolic HF · HFrEF",
    "stage": "Stage 2 · Heart failure",
    "sig": "Flat, wide, shifted right",
    "desc": "The defining lesion is a flattened ESPVR (low Ees). The ventricle dilates to compensate (Frank–Starling), so EDV rises but SV and EF fall. Coupling is badly deranged (Ea/Ees ≫ 1).",
    "chips": [
      "↓↓Ees",
      "↑EDV",
      "EF <40%"
    ],
    "evidence": "Guideline HFrEF (EF ≤40%). Eccentric remodelling flattens and shifts the ESPVR. Burkhoff 2005.",
    "teach": "<p>HFrEF is a <strong>contractility problem</strong>: the ESPVR flattens. The ventricle cannot generate pressure, so it dilates to keep stroke volume up. The loop shifts far to the right.</p><p>EDV rises but ESV rises more, so <em>ejection fraction falls below 40%</em>. Chronic eccentric remodelling makes the chamber more compliant, which is why filling pressure stays survivable despite the large volume.</p><div class=\"pearl\"><b>Why afterload reduction works:</b> with a flat ESPVR, a small drop in Ea buys a large gain in SV. Try lowering MAP.</div>"
  },
  "hfpef": {
    "name": "Diastolic HF (HFpEF)",
    "short": "Diastolic HF · HFpEF",
    "stage": "Stage 2 · Heart failure",
    "sig": "Narrow loop, steep floor",
    "desc": "A stiff ventricle (steep EDPVR) cannot fill at normal pressure. EF is preserved but the loop is small and end-diastolic pressure is high. This is congestion with a normal EF.",
    "chips": [
      "↑↑EDPVR",
      "EF ≥50%",
      "↑LVEDP"
    ],
    "evidence": "HFpEF (EF ≥50%). Steep EDPVR and raised filling pressure. Zile 2004; Borlaug 2020.",
    "teach": "<p>HFpEF is a <strong>filling problem</strong>. The EDPVR is steep and shifted up, so end-diastolic pressure is high even though the chamber is small.</p><p>Systolic function (ESPVR) is intact, so <em>ejection fraction stays ≥50%</em>, which is exactly why the diagnosis is missed. The pathology lives on the bottom border of the loop, not the top.</p><div class=\"pearl\"><b>Toggle the EDPVR overlay:</b> the steep exponential floor is the whole disease. High LVEDP → high left-atrial pressure → pulmonary congestion.</div>"
  },
  "shock": {
    "name": "Cardiogenic shock",
    "short": "Cardiogenic shock",
    "stage": "Stage 2 · Heart failure",
    "sig": "Collapsed loop, low pressure",
    "desc": "End-stage pump failure: a nearly flat ESPVR with hypotension. Output and pressure fall together, the loop collapses, and Ea/Ees is extreme. This is the substrate for mechanical support.",
    "chips": [
      "EF <25%",
      "↓↓CO",
      "↑↑Ea/Ees"
    ],
    "evidence": "SCAI shock stages; substrate for Impella/ECMO. DanGer Shock 2024.",
    "teach": "<p>Cardiogenic shock is HFrEF taken to the edge: a <strong>nearly flat ESPVR plus hypotension</strong>. Cardiac output and blood pressure fall together, and the loop collapses.</p><p>Ventriculo-arterial coupling is severely deranged. The ventricle can no longer match its load. This is the physiologic substrate where <em>mechanical circulatory support</em> is considered.</p><div class=\"pearl\"><b>Now layer on a device:</b> select Impella and watch the loop shrink and unload; select VA-ECMO and watch afterload and LV pressure climb.</div>"
  },
  "rcm": {
    "name": "Restrictive cardiomyopathy",
    "short": "Restrictive CM",
    "stage": "Stage 2 · Cardiomyopathy",
    "sig": "Tiny, very stiff loop",
    "desc": "Extreme diastolic stiffness (amyloid, fibrosis) with a small chamber. Systolic function is relatively preserved but filling is choked, giving a small loop with very high filling pressure.",
    "chips": [
      "↑↑↑EDPVR",
      "small EDV",
      "↑↑LVEDP"
    ],
    "evidence": "Infiltrative/restrictive physiology; steepest EDPVR. Cardiac amyloidosis.",
    "teach": "<p>Restrictive cardiomyopathy is HFpEF's severe cousin: an <strong>extremely steep EDPVR</strong> in a small, non-compliant chamber. Filling stops abruptly at high pressure.</p><p>The loop is small and tall-floored. EF can look near-normal, masking a ventricle that physically cannot accept volume. This is the hallmark of infiltrative disease such as amyloid.</p><div class=\"pearl\"><b>Distinguish from constriction:</b> restriction is a myocardial stiffness problem (this loop); constriction is a pericardial constraint the LV-only model can only approximate.</div>"
  },
  "hcm": {
    "name": "Hypertrophic cardiomyopathy",
    "short": "Hypertrophic CM",
    "stage": "Stage 2 · Cardiomyopathy",
    "sig": "Hyperdynamic, small cavity",
    "desc": "A thick, hypercontractile ventricle with a small, stiff cavity. ESPVR is steep (high EF, near-empty at end-systole) but the EDPVR is stiff. Dynamic outflow obstruction is not captured here.",
    "chips": [
      "↑↑Ees",
      "small cavity",
      "↑EDPVR"
    ],
    "evidence": "Sarcomeric HCM; hyperdynamic with diastolic dysfunction. Mavacamten (EXPLORER-HCM 2020).",
    "teach": "<p>HCM gives a <strong>hyperdynamic, small-cavity</strong> loop: a steep ESPVR empties the ventricle almost completely (high EF), while a stiff EDPVR impairs filling.</p><p>The main clinical problem, <em>dynamic LVOT obstruction</em>, depends on flow, geometry and SAM, which a lumped single-chamber model cannot represent. Read this loop as the substrate, not the gradient.</p><div class=\"pearl\"><b>Myosin inhibitors (mavacamten)</b> deliberately lower Ees to relieve obstruction. This is the opposite of an inotrope.</div>"
  },
  "htnheart": {
    "name": "Hypertensive heart disease",
    "short": "Hypertensive heart",
    "stage": "Stage 2 · Cardiomyopathy",
    "sig": "Tall loop, high pressure",
    "desc": "Chronic pressure overload: high afterload with concentric hypertrophy that stiffens the EDPVR. EF is preserved early; peak pressures are high and the loop is tall.",
    "chips": [
      "↑afterload",
      "concentric LVH",
      "↑EDPVR"
    ],
    "evidence": "Pressure-overload concentric remodelling; precursor to HFpEF.",
    "teach": "<p>Sustained hypertension is <strong>chronic afterload overload</strong>. The ventricle answers with concentric hypertrophy: thicker walls that generate high pressure but stiffen diastole.</p><p>Early on EF is preserved and the loop is simply tall. Over years the stiff EDPVR dominates and the picture converges on <em>HFpEF</em>.</p><div class=\"pearl\"><b>The through-line:</b> hypertensive heart → concentric LVH → HFpEF is one continuous EDPVR-steepening story.</div>"
  },
  "as": {
    "name": "Aortic stenosis",
    "short": "Aortic stenosis (AS)",
    "stage": "Stage 3 · Valvular",
    "sig": "Tall loop, LV≫Ao pressure",
    "desc": "A fixed obstruction the ventricle must overcome. Peak LV pressure rises far above aortic pressure. That difference is the trans-valvular gradient. The loop becomes tall and pressure-loaded with concentric hypertrophy.",
    "chips": [
      "peak LVP≫Ao",
      "↑gradient",
      "concentric LVH"
    ],
    "evidence": "Severe AS (Vmax ≥4 m/s, AVA ≤1 cm²). Class I for AVR when symptomatic. 2020 ACC/AHA VHD.",
    "teach": "<p>AS is an <strong>outflow obstruction</strong>. The ventricle generates a much higher pressure than the aorta ever sees. The difference is the <em>trans-valvular gradient</em>.</p><p>Toggle <strong>Peak LV pressure</strong> and <strong>Aortic pressure lines</strong>: the gap between them is the gradient, and it is the whole disease. Chronic pressure overload drives concentric hypertrophy and a stiffer EDPVR.</p><div class=\"pearl\"><b>Why this matters:</b> in every other condition here, peak LVP ≈ aortic SBP. AS is the exception, and that gap is what a valve replacement erases.</div>"
  },
  "ai": {
    "name": "Chronic aortic regurgitation",
    "short": "Aortic regurg · chronic",
    "stage": "Stage 3 · Valvular",
    "sig": "Huge, wide loop, low DBP",
    "desc": "Diastolic backflow volume-overloads the ventricle. It dilates eccentrically to accommodate a very large total stroke volume, with a wide pulse pressure and low aortic diastolic pressure.",
    "chips": [
      "↑↑EDV",
      "wide PP",
      "low DBP"
    ],
    "evidence": "Chronic severe AR; eccentric remodelling. AVR by LVESD/EF criteria. 2020 ACC/AHA VHD.",
    "teach": "<p>In aortic regurgitation, blood leaks <strong>back into the ventricle during diastole</strong>. The loop loses its clean isovolumic relaxation. Volume keeps entering as pressure falls.</p><p>Chronic AR gives the heart time to dilate eccentrically, so it carries a huge total stroke volume at survivable filling pressure. The runoff back through the valve drops <em>aortic diastolic pressure</em>, widening the pulse pressure.</p><div class=\"pearl\"><b>Compare with acute AR:</b> same leak, but no time to remodel. The small stiff ventricle raises its filling pressure instead of dilating.</div>"
  },
  "acuteai": {
    "name": "Acute aortic regurgitation",
    "short": "Aortic regurg · acute",
    "stage": "Stage 3 · Valvular",
    "sig": "Normal-size LV, ↑↑LVEDP",
    "desc": "A sudden severe leak (endocarditis, dissection) into a normal, non-dilated ventricle. It cannot accommodate the volume, so LV end-diastolic pressure rises sharply. This is a surgical emergency.",
    "chips": [
      "non-dilated",
      "↑↑LVEDP",
      "emergency"
    ],
    "evidence": "Acute severe AR: surgical emergency; premature MV closure on echo.",
    "teach": "<p>Acute AR is a <strong>different disease</strong> from the chronic form. The leak is just as severe, but the ventricle is normal-sized and stiff. It has had no time to dilate.</p><p>Unable to accommodate the regurgitant volume, <em>end-diastolic pressure rises steeply</em>. Clinically this can slam the mitral valve shut early and cause flash pulmonary oedema.</p><div class=\"pearl\"><b>Chronic vs acute is the exam favourite:</b> same lesion, opposite loops, because remodelling either had time to happen or it did not.</div>"
  },
  "ms": {
    "name": "Mitral stenosis",
    "short": "Mitral stenosis (MS)",
    "stage": "Stage 3 · Valvular",
    "sig": "Small loop, shifted left",
    "desc": "The obstruction is at inflow, upstream of the ventricle. The LV underfills, so SV falls, but LV systolic function and EF are preserved. The pressure and the problem are in the left atrium.",
    "chips": [
      "↓filling",
      "↓SV",
      "↑LAP"
    ],
    "evidence": "Rheumatic MS; gradient across MV → ↑LAP/PCWP. Balloon valvuloplasty / MVR.",
    "teach": "<p>Mitral stenosis is unique here: the lesion sits <strong>upstream of the ventricle</strong>. The LV simply cannot fill, so the loop is small and shifted left with a reduced stroke volume.</p><p>Crucially, LV contractility and <em>ejection fraction are preserved</em>. The ventricle is normal, it is simply underfilled. The high pressure and the pathology are in the left atrium (↑LAP, ↑PCWP), which this LV-only loop cannot show.</p><div class=\"pearl\"><b>Reading tip:</b> a small loop with a normal-shaped ESPVR and preserved EF points upstream. Think inflow obstruction, not pump failure.</div>"
  },
  "amr": {
    "name": "Chronic mitral regurgitation",
    "short": "Mitral regurg · chronic",
    "stage": "Stage 3 · Valvular",
    "sig": "Wide loop, no isovolumic phases",
    "desc": "Systolic backflow into the low-pressure atrium. The ventricle ejects the moment pressure exceeds atrial pressure, so isovolumic contraction is lost. EF looks high but forward output is reduced.",
    "chips": [
      "no true IVC",
      "↑EDV",
      "deceptive EF"
    ],
    "evidence": "Chronic primary MR; EF overstates function. Repair is preferred to replacement. 2020 VHD.",
    "teach": "<p>In MR the ventricle has a <strong>low-pressure escape route</strong> into the left atrium. It starts ejecting as soon as LV pressure passes atrial pressure, so there is <em>no true isovolumic contraction</em>. The top-left corner of the loop is gone.</p><p>Because part of the ejection is backward, <strong>EF overstates real function</strong>: a \"normal\" EF of 65% may hide meaningful systolic impairment. Chronic MR dilates the ventricle eccentrically.</p><div class=\"pearl\"><b>Surgical trap:</b> after repair, EF often falls. The low-pressure escape route is gone and true function is unmasked. Operate before EF <60%.</div>"
  },
  "acutemr": {
    "name": "Acute mitral regurgitation",
    "short": "Mitral regurg · acute",
    "stage": "Stage 3 · Valvular",
    "sig": "Non-dilated LV, high LAP",
    "desc": "A sudden leak (papillary muscle rupture, chordal rupture) into a normal-sized, stiff atrium. Forward output crashes and left atrial and PCWP pressures rise sharply. The result is cardiogenic shock and flash pulmonary oedema.",
    "chips": [
      "non-dilated",
      "↑↑LAP",
      "shock"
    ],
    "evidence": "Acute severe MR: papillary rupture after MI; giant v-waves. Emergent surgery.",
    "teach": "<p>Acute MR is the emergency form: the leak hits a <strong>normal, non-compliant left atrium</strong>. Pressure has nowhere to go, so LA (and PCWP) pressure spikes with giant v-waves.</p><p>The ventricle is hyperdynamic and small, but <em>forward output collapses</em>. The picture is flash pulmonary oedema and cardiogenic shock, classically after papillary-muscle rupture in acute MI.</p><div class=\"pearl\"><b>Same lesion, remodelling makes the loop:</b> chronic MR dilates and compensates; acute MR cannot, and decompensates fast.</div>"
  },
  "pre_tavr": {
    "name": "Before TAVR (severe AS)",
    "short": "Pre-TAVR (severe AS)",
    "stage": "Stage 5 · Intervention",
    "sig": "Tall loop, large gradient",
    "pair": "post_tavr",
    "desc": "Severe symptomatic AS at the point of intervention: tall pressure-loaded loop, a wide LV–aortic gradient, concentric hypertrophy and a stiff EDPVR.",
    "chips": [
      "peak LVP≫Ao",
      "↑afterload",
      "symptomatic"
    ],
    "evidence": "PARTNER / Evolut: TAVR non-inferior to surgery across risk strata.",
    "teach": "<p>This is severe aortic stenosis just before valve replacement. The ventricle is generating a <strong>large gradient</strong> to force blood through a fixed orifice, with concentric hypertrophy behind it.</p><p>Switch to <em>After TAVR</em> to watch the intervention: the gradient collapses, afterload falls, and the loop widens as forward stroke volume recovers.</p><div class=\"pearl\"><b>Watch peak LVP:</b> before, it towers over aortic pressure; after, they converge. That collapse is the entire haemodynamic benefit.</div>"
  },
  "post_tavr": {
    "name": "After TAVR",
    "short": "Post-TAVR",
    "stage": "Stage 5 · Intervention",
    "sig": "Gradient gone, loop widens",
    "pair": "pre_tavr",
    "desc": "The orifice is restored. Peak LV pressure now sits at aortic systolic pressure, afterload drops, SV rises, and the loop normalises. Hypertrophy regresses over months.",
    "chips": [
      "peak LVP≈Ao",
      "↓afterload",
      "↑SV"
    ],
    "evidence": "Immediate afterload relief; reverse remodelling over months. PARTNER long-term.",
    "teach": "<p>The valve is fixed. Peak LV pressure and aortic systolic pressure are <strong>reunited</strong>: the gradient is gone. The abrupt fall in afterload lets stroke volume rise.</p><p>Toggle back to <em>Before TAVR</em> to see the contrast. The concentric hypertrophy and stiff EDPVR take months to regress, so filling pressure improves more slowly than output.</p><div class=\"pearl\"><b>Occasional paradox:</b> EF can dip transiently after relief, unmasking systolic dysfunction the high afterload had been propping up.</div>"
  },
  "pre_mvr": {
    "name": "Before MV surgery (severe MR)",
    "short": "Pre-MVR (severe MR)",
    "stage": "Stage 5 · Intervention",
    "sig": "Wide loop, deceptive EF",
    "pair": "post_mvr",
    "desc": "Severe chronic MR at the point of surgery: a dilated ventricle with a wide loop, high total SV, and an EF that flatters true function because of the low-pressure regurgitant path.",
    "chips": [
      "↑↑EDV",
      "no IVC",
      "EF flattered"
    ],
    "evidence": "Primary MR: repair before EF <60% or LVESD >40 mm. 2020 ACC/AHA VHD.",
    "teach": "<p>Severe chronic MR just before surgery: dilated ventricle, wide loop, no isovolumic contraction, and a <strong>deceptively preserved EF</strong>.</p><p>Switch to <em>After MV surgery</em>. Restoring valve competence removes the backward escape. End-diastolic volume falls and true function is revealed, sometimes with a lower EF than before.</p><div class=\"pearl\"><b>Timing is everything:</b> operate while EF is still ≥60% and LVESD <40 mm, before irreversible dysfunction hides behind the leak.</div>"
  },
  "post_mvr": {
    "name": "After MV surgery",
    "short": "Post-MVR",
    "stage": "Stage 5 · Intervention",
    "sig": "IVC restored, EF unmasked",
    "pair": "pre_mvr",
    "desc": "Valve competence restored: isovolumic contraction returns, end-diastolic volume falls, forward output improves, and EF often drops as true systolic function is unmasked.",
    "chips": [
      "IVC returns",
      "↓EDV",
      "true EF"
    ],
    "evidence": "Post-repair EF fall is expected. The low-impedance leak is gone.",
    "teach": "<p>The valve is competent again. The top-left corner of the loop, <strong>isovolumic contraction</strong>, reappears, and the dilated ventricle shrinks toward normal.</p><p>Forward stroke volume improves, but <em>EF may fall</em>: without the low-pressure escape route, the ventricle's real contractile state shows through. That drop is expected, not a complication.</p><div class=\"pearl\"><b>Repair beats replacement</b> for long-term LV function whenever the valve anatomy allows it.</div>"
  },
  "pre_crtp": {
    "name": "Before CRT (LBBB + HFrEF)",
    "short": "Pre-CRT (dyssynchrony)",
    "stage": "Stage 5 · Intervention",
    "sig": "Wide, flat, wasteful loop",
    "pair": "post_crtp",
    "desc": "Dyssynchronous HFrEF: left bundle branch block makes the septum and free wall contract out of phase, wasting work as functional MR and a low, flat loop.",
    "chips": [
      "↓Ees",
      "functional MR",
      "wide QRS"
    ],
    "evidence": "CRT for EF ≤35%, LBBB, QRS ≥150 ms. MADIT-CRT; about 30% are non-responders.",
    "teach": "<p>In LBBB, the ventricle contracts <strong>out of sequence</strong>. The septum fires early and the free wall late. Force is wasted stretching still-relaxed segments rather than ejecting, and functional MR appears.</p><p>The loop is wide, flat and inefficient. Switch to <em>After CRT</em> to resynchronise: biventricular pacing recovers coordinated contraction, effectively raising functional contractility <strong>without any drug</strong>.</p><div class=\"pearl\"><b>CRT is mechanical, not pharmacologic:</b> it fixes timing. Best responders have EF ≤35%, true LBBB and QRS ≥150 ms.</div>"
  },
  "post_crtp": {
    "name": "After CRT",
    "short": "Post-CRT (resynchronised)",
    "stage": "Stage 5 · Intervention",
    "sig": "Loop lifts and narrows",
    "pair": "pre_crtp",
    "desc": "Biventricular pacing restores synchronous contraction: functional contractility rises, functional MR falls, and the loop lifts and narrows. Reverse remodelling follows over months.",
    "chips": [
      "↑functional Ees",
      "↓MR",
      "reverse remodel"
    ],
    "evidence": "Acute resynchronisation + chronic reverse remodelling. CARE-HF, MADIT-CRT.",
    "teach": "<p>Resynchronisation recoordinates the contraction. Functional contractility rises, functional MR falls, and the loop <strong>lifts and narrows</strong>. There is more stroke volume for less wasted work.</p><p>The acute benefit is immediate; <em>reverse remodelling</em> then shrinks the ventricle over 3–6 months. Compare with <em>Before CRT</em> to see both the height gain and the width reduction.</p><div class=\"pearl\"><b>~30% of patients are non-responders</b>. Patient selection by QRS morphology and duration is critical.</div>"
  }
}